Viewing Study NCT06393361


Ignite Creation Date: 2025-12-24 @ 12:18 PM
Ignite Modification Date: 2025-12-27 @ 10:06 PM
Study NCT ID: NCT06393361
Status: RECRUITING
Last Update Posted: 2024-08-26
First Post: 2024-04-28
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Chidamide+Decitabine Plus Anti-PD-1 Antibody for Patients With R/R cHL Who Are Transplant-ineligible or Refused Transplant.
Sponsor: Chinese PLA General Hospital
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module